Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Dose Finding Study of KL001 in Moderately Severe to Severe Hemophilia B Subjects

NCT06125756 is registered in ClinicalTrials.gov with Affiliated Hospital of Guangdong Medical University as lead sponsor.

NCT NCT06125756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06125756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Dose Finding Study of KL001 in Moderately Severe to Severe Hemophilia B Subjects
Lead sponsor
Affiliated Hospital of Guangdong Medical University
Phase
Phase 1
Overall status
Unknown status
Start date
December 20, 2023
Completion date
October 30, 2025
Enrollment
9 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b without inhibitor